Method for treating multiple sclerosis
AssigneeChina Medical University
InventorsWoei-Cherng Shyu, Chen-Huan Lin, Wei Lee, Chia-Hung Hsieh, Chung-Y Hsu, Chang-Hai Tsai
Life of this patent
Estimating the term…
Abstract
A method for treating a multiple sclerosis is provided. The method includes administering a composition containing a plurality of mesenchymal stem cells to a subject in need for a treatment of the multiple sclerosis, in which each of the mesenchymal stem cells expresses insulin-like growth factor 1 receptors.
Claims5
A method for treating a multiple sclerosis, the method comprising administering a composition containing a plurality of insulin-like growth factor 1 receptor positive umbilical cord mesenchymal stem cells to a subject in need for a treatment of the multiple sclerosis, wherein each of the umbilical cord mesenchymal stem cells is derived from Wharton's jellies and isolated by using an insulin-like growth factor 1 receptor antibody and then cultured in a medium containing platelet-derived growth factor BB (PDGF-BB) at 2.5-50 ng/mL to enhance the expression of insulin-like growth factor 1 receptors in the umbilical cord mesenchymal stem cells, wherein the composition is administered by an intravenous injection.
Dependencies are inferred from the claim text.